Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
Conditions
Interventions
- RADIATION: SCRT
- DRUG: Retlirafusp alfa Injection
- DRUG: Bevacizumab
- DRUG: CAPOX
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators